|
Newsletter of Current Issues in HIV/AIDS
Index of Issues: 2000 to Present
2007
July – December 2007
Human Rights and HIV/AIDS in Brazil; AIDS Vaccine Update; LIV Lipodystrophy; Migration and HIV
April – June 2007
Special Issue on HIV and Aging: Reality Demands Change; Depression, Distress, HIV, and Aging; Cardiovascular Disease and HIV; Taking Care of Each Other
January – March 2007
The End of Nandrolone; The International Narcotics Control Board and HIV/AIDS; Money, Moralism, and Microbicides: Barriers in Microbicides Development; A Rare Moment in Time
2006
August – December 2006
Maraviroc in the home stretch. Tracking maraviroc in Treatment Issues. Webcasts offer latest research
on HIV and more. Theo Smart on the difficult diagnosis of tuberculosis. FDA Hearing on HCV drug development. Pregnancy outcomes in DART study. Rapidly progressing HCV in gay men.
April – July
2006
The world needs better HIV drugs. The global need for Kaletra.
Increasing access to tenofovir. Treating HIV and HCV in the same
person. Testing the next generation of HIV drugs
January – March
2006
Uncertain future for early drug access programs. The history of early
access for HIV drugs. Programs place big burden on research sites.
Ethical review of research protects patients. Universal access to
ARVs requires stronger health systems. GMHC Action Center demands
more treatment research for women.
2005
December 2005
AIDS is Still a Political Crisis: Gregg Gonsalves on the vanishing
voice of people with HIV. Planning for Tomorrow: Young investigators
tackle AIDS Research. Birth Defects and HIV: No unexpected link
seen. The Genital Herpes Connection: Increased risk for HIV?
Who Are the Elite Controllers? Suppressing HIV without drugs.
September/November
2005
European AIDS Conference: Satellite sessions keep the faith and
pay the bills. Interview with Dr. Joseph Sonnabend: The doctor/patient
relationship is key. Simplified diagnostics for the developing
world: Is too much data a danger?
July/August 2005
Crystal meth conference: exploring solutions from all sides. Treating
methamphetamine dependency. Tracking the sources of Meth. Allan
Clear and Luciano Colonna on next steps.
May/June 2005
Preventing HPV: vaccines are on the way. Aptivus arrives. FDA shoptalk.
Immunology summit. Invisible injection drug users.
March/April 2005
HIV-associated fat problems: What is happening to my body? Will
treatment programs succeed in the developing world? Treatment
activists go generic in Mumbai. Strengthening national health
systems.
January/February
2005
The New York "Super Virus": Was the alarm justified? Men, Meth,
and Sex. The Feminization of AIDS: Tough choices for African leaders.
The Retrovirus Conference Webcasts. Return of the Supertramp.
2004
November/December
2004
The nevirapine whistleblower mess; Rethinking mother-to-child transmission;
The federal public policy outlook; research standards here and
there.
September/October
2004
Voices from all over: AIDS activists look ahead. My doctors doesn't
hear me. Flu: the coup. After the election.
July/August 2004
Drug users speak out at the International AIDS Conference; science
news from Bangkok; Bush & Kerry health proposals compared; Charles
Clifton remembered. Visit GMHC's IAC
2004 Photo Gallery.
May/June 2004
Gender inequality and AIDS; ARVs and women in India; drug news;
wrong direction for NIH trials networks?
March/April 2004
Work and HIV: Making a safe transition to employment; understand
your benefits and options first; why work matters.
January/February
2004
Genetic factors in HIV progression; 11th Retrovirus Conference
on the Web; International Drug Pricing Q&A; Boondoggle at the
NIH.
2003
December 2003
AIDS advocacy on the rise; SAVE ADAP push announced;
400% Norvir price hike sparks Abbott boycott; T-1249 development
suspended.
November 2003
Prescription drug prices are driving the coming crisis in health
care; Are viral load "blips" a cause for alarm?; AIDS activists
meet the FDA.
October 2003
The Burden of Disease: Coinfections and comorbitities. HIV, HCV,
HBC, Tuberculosis and Malaria.
September 2003
Microbicides, Sexual transmission of HIV, Interview with Zena Stein,
Microbicide advocacy, Kaletra as a single agent HAART.
July/August 2003
Access to care, ART in Sub-Sarahan Africa, Médecins
Sans Frontières treatment projects worldwide, hepatitis
c, prevention in India, new drugs, treatment in South Africa.
June 2003
Alternative therapies, HIV and disability, Atazanavir dosing options,
and more.
May 2003
Showdown at the X4 Corral, Nevirapine-Based Fixed-Dose Combination
ARVs, Gilead's Viread International Access Program.
April 2003
HIV/AIDS care, New York City HIV/AIDS statistics, HAART-related
vascular disease and more about Fuzeon.
March 2003
All about Fuzeon, the first in a new class of HIV drugs called
fusion inhibitors. Also, the lack of HIV/AIDS drugs in Jamaica
and the problem with Zerit.
January/ February 2003
The social nature of our biology, women and HIV, salvage
therapy and structured treatment interruptions, the new US HIV/AIDS
budget.
December 2002
Five new HIV/AIDS drugs, New York ADAP cuts, interview with IAS
president, intervention in India.
November 2002
An in-depth look at treatment education.
October 2002
The case against Zerit, organ transplants, fighting HIV in Botswana,
drug fact sheet reviews.
September 2002
ADAP cuts, sexual transmission of HCV, protein interactions, rapid
testing.
July/August 2002
Coverage of the XIV International AIDS Conference in Barcelona,
drugs in development.
June 2002
Appeal to African religious leaders, advocacy and activism, adolescents
and condoms, microbicides, crucial wasting treatment withdrawn,
inaction.
May 2002
What immunity assays tell us.
April 2002
Spiraling drug prices and Medicaid, ADAP cuts and restrictions,
fighting patent monopolies, drug industry reform, PhRMA, Mary
Delaney on drug pricing.
March 2002
HAART, new HIV targets, T-20 personal diary, nevirapine, vaccine
testing.
February 2002
Rapid testing, patents and HIV medicine, independent review, breast-feeding,
gene patenting.
January 2002
Genetics and recovery, primer on proteins, P-glycoprotein, HIV
campaign in an Islamic school, SMART study.
November/December 2001
Diagnostic tools, brain donor, adefovir, ICAAC report, once-a-day
dosing, financial disclosure.
October 2001
Researchers' and subjects' motives, tenofovir, ICAAC, rethinking
priorities.
September 2001
Catholic healthcare, HIV SNPs, "endpoints," treatment strategies.
July/August 2001
A look at drug development costs, malaria and HIV, drug levels
in the human body.
June 2001
Justice in South Africa, understanding scientific papers (part
3), direction of treatments.
May 2001
Federal treatment research, wasting, understanding scientific papers
(part 2), clinical research, AACTG.
April 2001
T-20 delay, worldwide AIDS treatment, understanding scientific
papers (part 1), HCV, HIV drugs in women.
February/March 2001
Federal treatment guidelines, HAART, sinusitis, lipids, recalling
Michael Callen.
January 2001
Nevirapine toxicity, medical terminology, drug recycling, new drug
news.
November/December 2000
Blood-donating discrimination, vaccine hopes, protease inhibitor
benefits.
September/October 2000
Durban, mother-to-child transmission, body fat changes.
Spring 2000
Changing views on when to start therapy, response to AIDS denialists,
lipodystrophy and mitochondria toxicity updates, information
on treatment strategies.
© 2004 Gay Men's Health Crisis
|
home 
